Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | EXP | | 6480464 | Demecolcine results in increased expression of ZBTB10 mRNA | CTD | PMID:23649840 | 1,2-dimethylhydrazine | decreases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ZBTB10 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of ZBTB10 mRNA | CTD | PMID:29097150 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ZBTB10 mRNA | CTD | PMID:19619570 | 17beta-estradiol | decreases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of ZBTB10 mRNA | CTD | PMID:32145629 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of ZBTB10 mRNA | CTD | PMID:19619570 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of ZBTB10 mRNA | CTD | PMID:16751804 and PMID:17010675 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of ZBTB10 mRNA | CTD | PMID:29581250 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Zbtb10 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:19095052 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Zbtb10 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ZBTB10 mRNA | CTD | PMID:19619570 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZBTB10 mRNA | CTD | PMID:19619570 | 2-hydroxypropanoic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of ZBTB10 mRNA | CTD | PMID:30851411 | 6-propyl-2-thiouracil | increases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of ZBTB10 mRNA | CTD | PMID:24780913 | 6-propyl-2-thiouracil | decreases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ZBTB10 mRNA | CTD | PMID:30047161 | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of ZBTB10 protein | CTD | PMID:20106945 | amitrole | decreases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of ZBTB10 mRNA | CTD | PMID:30047161 | ammonium chloride | affects expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of ZBTB10 mRNA | CTD | PMID:16483693 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of ZBTB10 mRNA | CTD | PMID:24449571 | arsane | affects expression | EXP | | 6480464 | Arsenic affects the expression of ZBTB10 mRNA | CTD | PMID:18414638 | arsenic atom | affects expression | EXP | | 6480464 | Arsenic affects the expression of ZBTB10 mRNA | CTD | PMID:18414638 | avobenzone | increases expression | EXP | | 6480464 | avobenzone results in increased expression of ZBTB10 mRNA | CTD | PMID:31016361 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of ZBTB10 exon | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ZBTB10 mRNA | CTD | PMID:22576693 | bisphenol A | decreases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ZBTB10 mRNA | CTD | PMID:33221593 | bisphenol A | increases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ZBTB10 mRNA | CTD | PMID:30816183 and PMID:33296240 | bisphenol A | decreases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ZBTB10 mRNA | CTD | PMID:25181051 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ZBTB10 gene | CTD | PMID:22576693 | carbon nanotube | decreases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of ZBTB10 mRNA | CTD | PMID:25554681 | chromium(6+) | increases expression | EXP | | 6480464 | chromium hexavalent ion results in increased expression of ZBTB10 mRNA | CTD | PMID:17382205 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ZBTB10 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of ZBTB10 mRNA | CTD | PMID:27392435 | clorgyline | increases expression | EXP | | 6480464 | Clorgyline results in increased expression of ZBTB10 mRNA | CTD | PMID:19691856 | clotrimazole | decreases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Clotrimazole results in decreased expression of ZBTB10 mRNA | CTD | PMID:30047161 | cobalt dichloride | increases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | cobaltous chloride results in increased expression of ZBTB10 mRNA | CTD | PMID:24386269 | colforsin daropate hydrochloride | decreases expression | EXP | | 6480464 | Colforsin results in decreased expression of ZBTB10 mRNA | CTD | PMID:16751804 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of ZBTB10 mRNA | CTD | PMID:19549813 | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of ZBTB10 mRNA | CTD | PMID:19167446 | crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos and Crocidolite results in increased expression of ZBTB10 mRNA | CTD | PMID:18687144 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ZBTB10 mRNA | CTD | PMID:20106945 and PMID:25562108 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ZBTB10 mRNA | CTD | PMID:29803840 | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of ZBTB10 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB10 mRNA | CTD | PMID:27188386 | fenvalerate | increases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of ZBTB10 mRNA | CTD | PMID:30307764 | fluoranthene | multiple interactions | ISO | Zbtb10 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZBTB10 mRNA | CTD | PMID:28329830 | folic acid | decreases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ZBTB10 mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of ZBTB10 mRNA | CTD | PMID:23649840 | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of ZBTB10 protein | CTD | PMID:37730182 | geraniol | increases expression | EXP | | 6480464 | geraniol results in increased expression of ZBTB10 mRNA | CTD | PMID:27683099 | hydrogen cyanide | increases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | Hydrogen Cyanide results in increased expression of ZBTB10 mRNA | CTD | PMID:33914522 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of ZBTB10 mRNA | CTD | PMID:28988120 | lipopolysaccharide | multiple interactions | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ZBTB10 mRNA | CTD | PMID:16415329 | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of ZBTB10 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ZBTB10 mRNA | CTD | PMID:35811015 | manganese(II) chloride | increases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of ZBTB10 mRNA | CTD | PMID:28801915 | mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of ZBTB10 mRNA | CTD | PMID:16823088 | mercury dibromide | decreases expression | EXP | | 6480464 | mercuric bromide results in decreased expression of ZBTB10 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB10 mRNA | CTD | PMID:27188386 | mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of ZBTB10 mRNA | CTD | PMID:16823088 | methimazole | decreases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of ZBTB10 mRNA | CTD | PMID:30047161 | methylisothiazolinone | increases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of ZBTB10 mRNA | CTD | PMID:31629900 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of ZBTB10 mRNA | CTD | PMID:28001369 | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of ZBTB10 mRNA | CTD | PMID:24810058 | N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine | multiple interactions | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ZBTB10 mRNA | CTD | PMID:16415329 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of ZBTB10 mRNA | CTD | PMID:23195993 and PMID:24768652 | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of ZBTB10 mRNA | CTD | PMID:25583101 | nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of ZBTB10 mRNA | CTD | PMID:17382205 | orphenadrine | affects expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Orphenadrine affects the expression of ZBTB10 mRNA | CTD | PMID:23665939 | ozone | multiple interactions | ISO | Zbtb10 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ZBTB10 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ZBTB10 mRNA | CTD | PMID:26690555 | PCB138 | multiple interactions | ISO | Zbtb10 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorohexanesulfonic acid | decreases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ZBTB10 mRNA | CTD | PMID:37995155 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of ZBTB10 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB10 mRNA | CTD | PMID:27188386 | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of ZBTB10 mRNA | CTD | PMID:17382205 | potassium cyanide | increases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | Potassium Cyanide results in increased expression of ZBTB10 mRNA | CTD | PMID:33914522 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of ZBTB10 mRNA | CTD | PMID:21632981 | quercetin | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in decreased expression of ZBTB10 mRNA] more ... | CTD | PMID:23530649 and PMID:24173369 | quercetin 3-O-beta-D-galactopyranoside | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in decreased expression of ZBTB10 mRNA] more ... | CTD | PMID:24173369 | rac-lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of ZBTB10 mRNA | CTD | PMID:30851411 | ranitidine | multiple interactions | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ZBTB10 mRNA | CTD | PMID:16415329 | resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Quercetin] results in increased expression of ZBTB10 mRNA | CTD | PMID:23530649 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ZBTB10 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of ZBTB10 mRNA | CTD | PMID:23806026 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ZBTB10 mRNA | CTD | PMID:34032870 | Soman | increases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Soman results in increased expression of ZBTB10 mRNA | CTD | PMID:19281266 | tetrachloromethane | increases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of ZBTB10 mRNA | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of ZBTB10 mRNA | CTD | PMID:31919559 | titanium dioxide | decreases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ZBTB10 mRNA | CTD | PMID:29264374 | trichloroethene | increases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of ZBTB10 mRNA | CTD | PMID:25549359 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of ZBTB10 mRNA | CTD | PMID:24935251 | troglitazone | decreases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | troglitazone results in decreased expression of ZBTB10 mRNA | CTD | PMID:28973697 | tungsten | decreases expression | ISO | Zbtb10 (Mus musculus) | 6480464 | Tungsten results in decreased expression of ZBTB10 mRNA | CTD | PMID:30912803 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of ZBTB10 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ZBTB10 mRNA | CTD | PMID:29154799 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZBTB10 mRNA | CTD | PMID:24383497 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB10 mRNA | CTD | PMID:27188386 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ZBTB10 mRNA | CTD | PMID:23179753 | vinclozolin | increases expression | ISO | Zbtb10 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of ZBTB10 mRNA | CTD | PMID:23555832 | vincristine | increases expression | EXP | | 6480464 | Vincristine results in increased expression of ZBTB10 mRNA | CTD | PMID:23649840 | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of ZBTB10 mRNA | CTD | PMID:27188386 | |